Position in LNTH
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$435,550
+$183,046 QoQ
Shares Held
3,926
+17.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#272
of 467 holders
Holding Since
Dec 2024
6 quarters on record
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kestra Advisory Services, LLC holds $7,523,206 across 11 Drug Manufacturers - Specialty & Generic names. LNTH ranks #6 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
24,414 | $1,754,390 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
46,085 | $1,561,359 | |
| 3 | VTRS |
Viatris Inc
|
92,472 | $1,468,455 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
1,355 | $734,179 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
17,089 | $592,475 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
This page
|
3,926 | $435,550 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
11,937 | $293,769 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
5,224 | $242,968 |
All Filings in LNTH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $435,550 | 3,926 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $252,504 | 3,329 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $217,818 | 3,273 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $245,170 | 2,995 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $281,966 | 2,889 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $253,261 | 2,831 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||